Has anyone considered the following; I cannot short CYDY in my Ameritrade account. I was told by a compliance officer that the shorting of OTC securities is prohibited as they are non-marginable and cannot be hypothecated (lent out). Therefore, how is it that some people on this board are claiming their brokers are paying huge sums of interest to lend their shares out presumably for shorting? This makes absolutely zero sense. The second question one must ask is, if this is the case, then how is an uplisting such a good thing? I mean, everyone and their dog will be able to short CYDY once this is accomplished. Institutions and hedge funds can buy all they want currently, and, they don’t have to disclose their stakes unless over a certain percent of outstanding unlike on the NASDAQ. I think all that will change is we will get some analyst coverage for better or for worse and possibly some mutual fund ownership. So I guess my question is, why is everyone so hell bent on an uplisting and 100% convinced it’s a bullish scenario? I’d rather see just one indication finally approved after 7 years of holding...